$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained release pharmaceutical compositions 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/32
  • A61K-009/36
출원번호 US-0230156 (1981-01-30)
발명자 / 주소
  • Guley Paul C. (Plattsburgh NY) DeNeale Richard J. (Willsboro NY) Milosovich George (Rouses Point NY)
출원인 / 주소
  • American Home Products Corporation (New York NY 02)
인용정보 피인용 횟수 : 74  인용 특허 : 6

초록

Novel sustained release compositions comprising a core containing a drug, a seal coating surrounding the core and a sugar coating surround the seal coated core are disclosed.

대표청구항

A sustained release pharmaceutical composition comprising a compressed core, a seal coating surrounding the core and a sugar coating surrounding the seal coated core wherein, (a) the core comprises a drug in an amount of about 20% to about 70% by weight of the core, at least one pharmaceutically acc

이 특허에 인용된 특허 (6)

  1. Gallian Claude E. (Evansville IN), Film-coated matrix core tablet.
  2. Ohno Shigeru (Kamakuna JA) Sekigawa Fujio (Yono JA) Yamagishi Shokichi (Omiya JA), Method of coating pharmaceutical solid dosage forms.
  3. Huber ; Harold E., Nitrofurantoin sustained release tablet.
  4. McAinsh James (Macclesfield GB2) Rowe Raymond C. (Macclesfield GB2), Sustained release pharmaceutical composition.
  5. Sheth Prabhakar R. (Pearl River NY) Tossounian Jacques L. (Pine Brook NJ), Sustained release tablet formulations.
  6. Guy Michael G. (Ferdonia WI) Powers Richard G. (Saukville WI), Timed-release aspirin.

이 특허를 인용한 특허 (74)

  1. Hermelin Marc S. ; Kirschner Mitchell I. ; Levinson R. Saul, Anti-nausea compositions and methods.
  2. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Composition comprising drug, HPC, HPMC and PEO.
  3. Tice Thomas R. ; Gilley Richard M. ; Eldridge John H. ; Staas Jay K., Composition for delivering bioactive agents for immune response and its preparation.
  4. Ho,Thomas, Compositions for conjugated estrogens and associated methods.
  5. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  6. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  7. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  8. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  9. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  10. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  11. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  12. Odidi, Isa; Odidi, Amina, Controlled extended drug release technology.
  13. Chen Chih-Ming ; Xie Jianbo ; Jan Steve, Controlled release bupropion formulation.
  14. Glidden, Paul F.; Pilgrim, Alison J.; Hanson, Stephen R., Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor.
  15. Glidden, Paul F.; Pilgrim, Alison J.; Hanson, Stephen R., Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor.
  16. Odidi, Isa; Odidi, Amina, Controlled release delivery device comprising an organosol coat.
  17. DeCrosta Mark T. (Plainsboro NJ) Jain Nemichand B. (Monmouth Junction NJ) Rudnic Edward M. (Kendall Park NJ), Controlled release formulation.
  18. Jain Nemichand B. (Monmouth Junction NJ) Gertie Linda P. (Cinnaminson NJ) Rudnic Edward M. (Plainsboro NJ), Controlled release formulation.
  19. Jain Nemichand B. (Monmouth Junction NJ) Patel Mahendra R. (East Brunswick NJ), Controlled release formulation and method.
  20. Barcomb Reginald J., Controlled release of steroids from sugar coatings.
  21. Barcomb Reginald J., Controlled release of steroids from sugar coatings.
  22. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  23. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  24. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  25. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  26. Chen,Chih Ming; Cheng,Xiu Xiu, Controlled release oral dosage form of beta-adrenergic blocking agents.
  27. Ohm Andreas (Neuss DEX) Luchtenberg Helmut (Niederkassel DEX) Bcheler Manfred (Overath DEX) Rupp Roland (Leichlingen DEX) Feltkamp Heinrich (Hennef DEX), DHP delayed release preparation.
  28. Colombo Paolo (Pavia ITX) Conte Ubaldo (Varese ITX) Reiner Alberto (Como ITX), Delivery device for zero-order release of an active principle into a dissolution fluid and process for its preparation.
  29. Ohm Andreas (Neuss DEX) Luchtenberg Helmut (Niederkassel DEX) Bcheler Manfred (Overath DEX) Schmoll Josef (Wermelskirchen DEX) Rupp Roland (Leichlingen DEX) Porges Eduard (Cologne DEX) Nishioka Takaa, Dihydropyridine depot formulation.
  30. Lulla, Amar; Malhotra, Geena, Enteric coated formulation for bisphosphonic acids and salts thereof.
  31. Lulla,Amar; Malhotra,Geena, Enteric coated formulation for bisphosphonic acids and salts thereof.
  32. Mehta Atul M. (Ramsey NJ) Bachand Lizbeth A. (Plattsburgh NY) Leonard Thomas W. (Plattsburgh NY) Warner Ronald N. (Grand Isle VT), Formulations providing three distinct releases.
  33. Mehta Atul M. (Ramsey NJ) Bachand Lizbeth A. (Plattsburgh NY) Leonard Thomas W. (Plattsburgh NY) Warner Ronald N. (Grand Isle VT), Formulations providing three distinct releases.
  34. Weber John B. (Norwich NY) Covarrubias Jesus T. (Jeronimo MXX), Furazolidone dosage form.
  35. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Lamina comprising carboxyvinyl polymer.
  36. Hyunjo Kim ; Reza Fassihi, Matrix for controlled delivery of highly soluble pharmaceutical agents.
  37. Tice Thomas R. ; Gilley Richard M. ; Eldridge John H. ; Staas Jay K., Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their r.
  38. Tice Thomas R. ; Gilley Richard M. ; Eldridge John H. ; Staas Jay K., Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their.
  39. Tice Thomas R. ; Gilley Richard M. ; Eldridge John H. ; Staas Jay K., Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their.
  40. Tice Thomas R. ; Gilley Richard M. ; Eldridge John H. ; Staas Jay K., Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor.
  41. Lickrish, David; Zhang, Feng, Method of treatment of attention deficit hyperactivity disorder.
  42. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  43. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  44. Lickrish, David; Zhang, Feng, Methods of treatment of attention deficit hyperactivity disorder.
  45. Aoki Shigeru (Gifu JPX) Uesugi Keizo (Aichi JPX) Sakashita Shigeru (Gifu JPX) Kasai Masayoshi (Gifu JPX) Kayano Masanori (Saitama JPX), Multi-layer granule.
  46. Odidi, Isa; Odidi, Amina, Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors.
  47. Talwar, Naresh; Sen, Himadri; Staniforth, John N., Orally administered drug delivery system providing temporal and spatial control.
  48. Gergely Gerhard (Gartengasse 8 A-1050 Vienna ATX) Gergely Thomas (Gartengasse 8 A-1050 Vienna ATX) Gergely Irmgard (Gartengasse 8 A-1050 Vienna ATX), Pharamaceutical preparations in the form of instant granules or tablets and process for their manufacture.
  49. Odidi, Isa; Odidi, Amina, Pharmaceutical composition having reduced abuse potential.
  50. Guitard Patrice,FRX ; Haeberlin Barbara,CHX ; Link Rainer,DEX ; Richter Friedrich,DEX, Pharmaceutical compositions.
  51. Guitard, Patrice; Haeberlin, Barbara; Link, Rainer; Richter, Friedrich, Pharmaceutical compositions.
  52. Guitard, Patrice; Haeberlin, Barbara; Link, Rainer; Richter, Friedrich, Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions.
  53. Baker Richard W. (Mountain View CA) Brooke James W. (Sisters OR), Pharmaceutical delivery system.
  54. Zerbe Horst (Wilhelm-Busch-Str. 4 D-4282 Velen DEX), Pharmaceutical product in the form of a pellet with continuous, delayed medicament substance emission.
  55. Sharma, Vinay K., Preparation of micron-size pharmaceutical particles by microfluidization.
  56. Nugent Frederic J. (Sherwood Park CAX) Yen John K. C. (Oakville CAX), Process for preparing the combination products of triamterene and hydrochlorothiazide.
  57. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  58. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  59. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Pseudoephedrine brompheniramine therapy.
  60. Odidi, Isa; Odidi, Amina, Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems.
  61. Nagi Arwinder S., Rapamycin formulations for oral administration.
  62. Li, Boyong; Cheng, Xiu Xiu, Stable pharmaceutical compositions without a stabilizer.
  63. Li, Boyong; Cheng, Xiu Xiu, Stable pharmaceutical compositions without a stabilizer.
  64. Michelucci John J. (Plattsburgh NY) Sherman Deborah M. (Plattsburgh NY) DeNeale Richard J. (Willsboro NY), Sustained release etodolac.
  65. Baichwal Anand R., Sustained release excipient.
  66. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release formulations of guaifenesin and additional drug ingredients.
  67. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release formulations of guaifenesin and additional drug ingredients.
  68. Baichwal, Anand R., Sustained release heterodisperse hydrogel systems for insoluble drugs.
  69. Baichwal, Anand, Sustained release heterodisperse hydrogel systems-amorphous drugs.
  70. Oren Peter L. (Noblesville IN) Seidler Werner M. K. (Indianapolis IN), Sustained release matrix.
  71. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin.
  72. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin combination drugs.
  73. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin combination drugs.
  74. Goudy ; Jr. Paul R. (Bayside WI) Cassedy Linn W. (Roselle IL) Whitaker Thomas S. (Bartlett IL), Tablet granulation.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로